Quantification of hepatitis B surface antigen and E antigen: correlation between Elecsys and architect assays. (Q43521365)

From Wikidata

Revision as of 16:34, 30 December 2018 by Edoderoobot (talk | contribs) (‎Updated Item: nl-description, python code, logfile on https://goo .gl/BezTim)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Quantification of hepatitis B surface antigen and E antigen: correlation between Elecsys and architect assays.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Quantification of hepatitis B surface antigen and E antigen: correlation between Elecsys and architect assays. (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

author name string

B Zhou

1

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

M Liu

2

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

G Lv

3

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

H Zheng

4

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Y Wang

5

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

J Sun

6

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

J Hou

7

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

publication date

25 March 2013

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Journal of Viral Hepatitis

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

20

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

422-429

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

A "NEW" ANTIGEN IN LEUKEMIA SERA

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12044

21 January 2018

EASL Clinical Practice Guidelines: management of chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12044

21 January 2018

Chronic hepatitis B: update 2009

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12044

21 January 2018

A comparison of two assays for quantification of Hepatitis B surface Antigen in patients with chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12044

21 January 2018

Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12044

21 January 2018

Quantitative serum HBsAg and HBeAg are strong predictors of sustained HBeAg seroconversion to pegylated interferon alfa‐2b in HBeAg‐positive patients

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12044

21 January 2018

Quantitative hepatitis B surface antigen and hepatitis B e antigen titers in prediction of treatment response to entecavir.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12044

21 January 2018

Hepatitis B virus surface antigen levels: a guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12044

21 January 2018

HBsAg profiles in patients receiving peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12044

21 January 2018

Low HBeAg serum levels correlate with the presence of the double A1762T/G1764A core promoter mutation and a positive response to interferon in patients with chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12044

21 January 2018

Hepatitis B e antigen seroconversion: a critical event in chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12044

21 January 2018

HBeAg and hepatitis B virus DNA as outcome predictors during therapy with peginterferon alfa-2a for HBeAg-positive chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12044

21 January 2018

Correlation between the Elecsys HBsAg II assay and the Architect assay for the quantification of hepatitis B surface antigen (HBsAg) in the serum

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12044

21 January 2018

Evaluation of two new automated assays for hepatitis B virus surface antigen (HBsAg) detection: IMMULITE HBsAg and IMMULITE 2000 HBsAg

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12044

21 January 2018

Recent developments in the diagnosis and monitoring of HBV infection and role of the genetic variability of the S gene

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12044

21 January 2018

Early serum HBsAg drop: A strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12044

21 January 2018

Identifiers

10.1111/JVH.12044

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43521365&oldid=823118158"